<SEC-DOCUMENT>0000876661-26-000646.txt : 20260727
<SEC-HEADER>0000876661-26-000646.hdr.sgml : 20260727
<ACCEPTANCE-DATETIME>20260727085748
ACCESSION NUMBER:		0000876661-26-000646
CONFORMED SUBMISSION TYPE:	25-NSE
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20260727
DATE AS OF CHANGE:		20260727
EFFECTIVENESS DATE:		20260727

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AVANOS MEDICAL, INC.
		CENTRAL INDEX KEY:			0001606498
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				464987888
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		25-NSE
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36440
		FILM NUMBER:		261202999

	BUSINESS ADDRESS:	
		STREET 1:		5405 WINDWARD PARKWAY
		STREET 2:		SUITE 100 SOUTH
		CITY:			ALPHARETTA
		STATE:			GA
		ZIP:			30004
		BUSINESS PHONE:		844-428-2667

	MAIL ADDRESS:	
		STREET 1:		5405 WINDWARD PARKWAY
		STREET 2:		SUITE 100 SOUTH
		CITY:			ALPHARETTA
		STATE:			GA
		ZIP:			30004

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Avanos Medical, Inc.
		DATE OF NAME CHANGE:	20180702

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Halyard Health, Inc.
		DATE OF NAME CHANGE:	20140424

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NEW YORK STOCK EXCHANGE LLC
		CENTRAL INDEX KEY:			0000876661
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			NY

	FILING VALUES:
		FORM TYPE:		25-NSE

	BUSINESS ADDRESS:	
		STREET 1:		11 WALL STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10005
		BUSINESS PHONE:		212-656-2060

	MAIL ADDRESS:	
		STREET 1:		11 WALL STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NEW YORK STOCK EXCHANGE INC
		DATE OF NAME CHANGE:	19910628
</SEC-HEADER>
<DOCUMENT>
<TYPE>25-NSE
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<notificationOfRemoval>

    <schemaVersion>X0203</schemaVersion>

    <exchange>
        <cik>0000876661</cik>
        <entityName>NEW YORK STOCK EXCHANGE LLC</entityName>
    </exchange>

    <issuer>
        <cik>0001606498</cik>
        <entityName>AVANOS MEDICAL, INC.</entityName>
        <fileNumber>001-36440</fileNumber>
        <address>
            <street1>5405 Windward Pkwy</street1>
            <city>Alpharetta</city>
            <stateOrCountryCode>GA</stateOrCountryCode>
            <stateOrCountry>GEORGIA</stateOrCountry>
            <zipCode>30004</zipCode>
        </address>
        <telephoneNumber>844-428-2667</telephoneNumber>
    </issuer>

    <descriptionClassSecurity>Common Stock</descriptionClassSecurity>

    <ruleProvision>17 CFR 240.12d2-2(a)(3)</ruleProvision>

    <signatureData>
        <signatureName>Anthony Sozzi</signatureName>
        <signatureTitle>Analyst, Market Watch</signatureTitle>
        <signatureDate>2026-07-27</signatureDate>
    </signatureData>
</notificationOfRemoval>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.25
<SEQUENCE>2
<FILENAME>ruleprovisionnotice.htm
<TEXT>
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES

The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on August 07, 2026, pursuant to the provisions of Rule 12d2-2 (a).

[ X ] 17 CFR 240.12d2-2(a)(3) That on July 27, 2026 the instruments representing the securities comprising the entire class of this security came to evidence, by operation of law or otherwise, other securities in substitution therefore and represent no other right except, if such be the fact, the right to receive an immediate cash payment.

The merger of Avanos Medical, Inc. and A-AV MergerSub, Inc., a wholly-owned subsidiary of A-AV Holdco I, Inc., which are affiliated with investment funds advised by American Industrial Partners became effective on July 27, 2026.  Each share of Common Stock of Avanos Medical, Inc. was converted into USD 25.00 in cash, without interest, less any applicable fee, and tax.

The Exchange also notifies the Securities and Exchange Commission that as a result of the above indicated conditions this security was suspended from trading on July 27, 2026.
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
